| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/04/2014 | US8642534 Proteins and polynucleotides of Vibrio cholerae |
| 02/04/2014 | US8642514 Encoded self-assembling chemical libraries (ESACHEL) |
| 02/04/2014 | US8642357 Semaphorin 7A plays a critical role in TGF-β1-induced pulmonary fibrosis and alveolar destruction |
| 02/04/2014 | US8642356 Cascade enzyme-linked immunosorbent assay |
| 02/04/2014 | US8642355 Versatile drug testing device |
| 02/04/2014 | US8642349 Artificial neural network proteomic tumor classification |
| 02/04/2014 | US8642348 Direct method and reagent kits for fatty acid ester synthesis |
| 02/04/2014 | US8642347 Urinary CA125 peptides as biomarkers of ovarian cancer |
| 02/04/2014 | US8642323 Container for testing for micro-organisms |
| 02/04/2014 | US8642322 Apparatus and methods for analyte measurement immunoassay |
| 02/04/2014 | US8642283 Screening assay for agents that alter target of rapamycin activity |
| 02/04/2014 | US8642281 Coelenterazine analogues and coelenteramide analogues |
| 02/04/2014 | US8642280 Teneurin and cancer |
| 02/04/2014 | US8642279 Method for predicting risk of metastasis |
| 02/04/2014 | US8642277 Tumor microenvironment of metastasis (TMEM) and uses thereof in diagnosis, prognosis and treatment of tumors |
| 02/04/2014 | US8642276 Method for the production of an immunostimulating mucin (MUC1) |
| 02/04/2014 | US8642275 Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method |
| 02/04/2014 | US8642274 Immunotherapeutic method |
| 02/04/2014 | US8642271 Aberrant methylation of C6Orf150 DNA sequences in human colorectal cancer |
| 02/04/2014 | US8642259 Method for identifying substances capable of modulating the activity of a target molecule |
| 02/04/2014 | US8642257 Vaccinia virus for diagnosis and therapy of tumors |
| 02/04/2014 | US8642100 Method to evaluate the quantity of methane produced by a dairy ruminant and method to reduce and control this quantity |
| 02/04/2014 | US8642050 Gonococcal proteins and nucleic acids |
| 02/04/2014 | US8642044 Prevention and treatment of amyloidogenic disease |
| 02/04/2014 | US8642037 Antibodies to insulin-like growth factor I receptor |
| 02/04/2014 | US8642032 Method for screening of patient to be administered with pharmaceutical agent comprising anti-cancer antibody as active ingredient |
| 02/04/2014 | US8641986 Assay cartridges and methods of using the same |
| 02/04/2014 | US8641643 Sampling module device and method |
| 02/04/2014 | US8640528 Lubrication condition monitoring |
| 02/04/2014 | US8640525 Methods and systems for differentiating soybeans |
| 02/04/2014 | DE202010018104U1 Probenplatte Sample plate |
| 02/04/2014 | CA2697520C Use of lyophilised reduced diaminophenothiazines in the treatment of tau mediated neurological disorders |
| 02/04/2014 | CA2687178C Polymeric carriers for immunohistochemistry and in situ hybridization |
| 02/04/2014 | CA2640551C Apparatus and methods for imaging and modification of biological samples |
| 02/04/2014 | CA2627317C Binding layer and method for its preparation and uses thereof |
| 02/04/2014 | CA2606250C Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 02/04/2014 | CA2569553C Collections of traceable compounds and uses thereof |
| 02/04/2014 | CA2548180C Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells |
| 02/04/2014 | CA2498008C Novel composition and methods for the treatment of immune related diseases |
| 02/04/2014 | CA2489740C Plastic injection-moulded part with embedded component |
| 02/04/2014 | CA2453470C Use of follistatin for the treatment of hepatic fibrogenesis |
| 02/04/2014 | CA2274801C Mammalian cell surface antigens; related reagents |
| 02/03/2014 | DE202014100241U1 Vorrichtung zum Messen und Sammeln von Sauerstoffkonzentrationsdaten bei Schweißprozessen Apparatus for measuring and collecting data on oxygen concentration welding processes |
| 02/03/2014 | DE202013005052U1 lndikatormaterial und lndikatormittel lndikatormaterial and lndikatormittel |
| 01/30/2014 | WO2014018960A1 Density amplification in magnetic levitation to detect binding events of large molecules |
| 01/30/2014 | WO2014018903A1 Autoantibody profiles in early detection and diagnosis of cancer |
| 01/30/2014 | WO2014018899A1 Electric measurement of monolayers following pro-cleave detection of presence and activity of enzymes and other target analytes |
| 01/30/2014 | WO2014018894A1 Continuous turbidimetric total iron monitoring |
| 01/30/2014 | WO2014018886A1 Electronic measurements of monolayers following homogeneous reactions of their components |
| 01/30/2014 | WO2014018851A1 Predicting and treating diabetic complications |
| 01/30/2014 | WO2014018774A1 Screening, diagnosis and prognosis of autism and other developmental disorders |
| 01/30/2014 | WO2014018770A1 Modular platform for multi-tissue integrated cell culture |
| 01/30/2014 | WO2014018719A1 System and method for quantitatively assessing diabetic cardiac autonomic neuropathy in type i diabetic biological subject |
| 01/30/2014 | WO2014018683A2 A novel method to detect resistance to chemotherapy in patients with lung cancer |
| 01/30/2014 | WO2014018643A1 Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (tia) and peripheral arterial disease (pad) |
| 01/30/2014 | WO2014018621A1 Method of predicting necrotizing enterocolitis |
| 01/30/2014 | WO2014018618A1 Methods and compounds for diagnosing threonyl-trna synthetase-associated diseases and conditions |
| 01/30/2014 | WO2014018554A1 Ptprs and proteoglycans in autoimmune disease |
| 01/30/2014 | WO2014018513A1 System and method for detecting and diagnosing schizophrenia and depression |
| 01/30/2014 | WO2014018468A1 Modulation sapp, sapp alpha and bdnf levels in individuals diagnosed with fxs and asd |
| 01/30/2014 | WO2014018464A1 Methods and compositions for diagnosis and prognosis of sepsis |
| 01/30/2014 | WO2014018357A1 Apparatus and method for measuring dielectic permittivity of cylindrical samples |
| 01/30/2014 | WO2014018314A1 Splash-retarding fluid collection system |
| 01/30/2014 | WO2014018286A1 Nanopillar field-effect and junction transistors with functionalized gate and base electrodes |
| 01/30/2014 | WO2014018097A1 Apparatus and methods for reducing electrical shock hazard from biosensor meters |
| 01/30/2014 | WO2014017940A1 System and process to assess physiological states of plant tissues, in vivo and/or in situ, using impedance techniques |
| 01/30/2014 | WO2014017932A1 System and method for contaminant detection in fluid streams |
| 01/30/2014 | WO2014017929A1 Method and system for microfluidic particle orientation and/or sorting |
| 01/30/2014 | WO2014017825A1 Exposure chamber apparatus for testing inhalation toxicity of nanoparticles in primates |
| 01/30/2014 | WO2014017737A1 Apparatus for detecting sodium in liquid |
| 01/30/2014 | WO2014017582A1 Method for detecting breakage of nucleic acid contained in single cell |
| 01/30/2014 | WO2014017491A1 Fusion gene of cep55 gene and ret gene |
| 01/30/2014 | WO2014017462A1 Pharmaceutical composition for inhibiting abnormal spine formation |
| 01/30/2014 | WO2014017319A1 Filaggrin production promoter, therapeutic agent for diseases associated with reduction in production of filaggrin, and method for screening for said therapeutic agent |
| 01/30/2014 | WO2014017116A1 Microwell array chip, and method for collecting cells |
| 01/30/2014 | WO2014017106A1 Compositions Comprising RAC Mutants, and Methods of Use Thereof |
| 01/30/2014 | WO2014016829A1 Insoluble fibrinogen particles (ifp) and coatings : composition, fabrication methods, and applications for harvesting and culturing mammalian cells |
| 01/30/2014 | WO2014016826A1 An in-shell scrambled egg, a method for preparing such and an in-shell egg scrambler |
| 01/30/2014 | WO2014016791A2 Reversible detection of ions with permselective membranes |
| 01/30/2014 | WO2014016605A1 Assay |
| 01/30/2014 | WO2014016586A1 Isotopic labelling of proteins |
| 01/30/2014 | WO2014016584A2 Diagnostic for determining skeletal health |
| 01/30/2014 | WO2014016465A1 Biosensor comprising metal nanoparticles |
| 01/30/2014 | WO2014016459A1 Method and device for determining chloride migration coefficients of partially water-saturated concretes |
| 01/30/2014 | WO2014016401A1 DETECTION OF THE ERα/SRC/PI3K COMPLEX AS PREDICTIVE MARKER IN BREAST CANCER |
| 01/30/2014 | WO2014016373A1 Protein level of c9orf72 for diagnosing a neurodegenerative disease |
| 01/30/2014 | WO2014016368A1 Method of determining a protein in a sample |
| 01/30/2014 | WO2014016358A1 Inhibition of hiv-1 infection by inhibition of binding of cpsf to viral capsid |
| 01/30/2014 | WO2014016309A1 Method for producing microcarriers and for performing biological assays |
| 01/30/2014 | WO2014016301A1 A protein microarray for characterizing the specificity of the monoclonal immunoglobulins of mgus or myeloma patients |
| 01/30/2014 | WO2014016284A1 Method for diagnosing scleroderma |
| 01/30/2014 | WO2014016263A1 Method for producing structured microcarriers |
| 01/30/2014 | WO2014016262A1 Method for producing microcarriers |
| 01/30/2014 | WO2014016236A1 Disposable test device |
| 01/30/2014 | WO2014015691A1 Blood gas analyzer and method of use thereof |
| 01/30/2014 | WO2014015687A1 White blood cell classifying and counting agent and white blood cell classifying method |
| 01/30/2014 | WO2014015530A1 Automatic detection device for a harmful gas |
| 01/30/2014 | WO2014015439A1 Titration of therapy through assay of cholesterol in skin by mass spectroscopy |
| 01/30/2014 | WO2013188623A9 Methods for predicting cardiotoxicity |
| 01/30/2014 | WO2013185029A3 The use of endotoxin neutralization as a biomarker for intestinal wall damage |